Pantoprazole and Lung adenocarcinoma metastatic - a phase IV clinical study of FDA data
Lung adenocarcinoma metastatic is found among people who take Pantoprazole, especially for people who are male, 60+ old.
The phase IV clinical study analyzes which people take Pantoprazole and have Lung adenocarcinoma metastatic. It is created by eHealthMe based on reports of 256,934 people who have side effects when taking Pantoprazole from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
256,934 people reported to have side effects when taking Pantoprazole.
Among them, 10 people (0.0%) have Lung adenocarcinoma metastatic.
What is Pantoprazole?
Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 260,152 Pantoprazole users for its effectiveness, alternative drugs and more.
What is Lung adenocarcinoma metastatic?
Lung adenocarcinoma metastatic (a form of non-small cell lung cancer spreads to other part) is found to be associated with 360 drugs and 168 conditions by eHealthMe.
Number of Pantoprazole and Lung adenocarcinoma metastatic reports submitted per year:
Gender of people who have Lung adenocarcinoma metastatic when taking Pantoprazole *:
- female: 33.33 %
- male: 66.67 %
Age of people who have Lung adenocarcinoma metastatic when taking Pantoprazole *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 14.29 %
- 60+: 85.71 %
Common drugs people take besides Pantoprazole *:
- Plavix: 5 people, 50.00%
- Simvastatin: 5 people, 50.00%
- Aspirin: 5 people, 50.00%
- Magnesium: 4 people, 40.00%
- Novolog: 3 people, 30.00%
- Levaquin: 3 people, 30.00%
- Digoxin: 3 people, 30.00%
- Meclizine: 3 people, 30.00%
- Captopril: 3 people, 30.00%
- Bumex: 3 people, 30.00%
Common side effects people have besides Lung adenocarcinoma metastatic *:
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 40.00%
- Hypersensitivity: 3 people, 30.00%
- Lung Carcinoma Cell Type Unspecified Stage Iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver): 3 people, 30.00%
- Acute Respiratory Failure: 3 people, 30.00%
- Chronic Respiratory Failure: 3 people, 30.00%
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 30.00%
- Dizziness: 3 people, 30.00%
- Encephalopathy (functioning of the brain is affected by some agent or condition): 3 people, 30.00%
- Gait Disturbance: 3 people, 30.00%
- Hepatic Failure (liver failure): 3 people, 30.00%
Common conditions people have *:
- Type 2 Diabetes: 2 people, 20.00%
- Cardiac Disorder: 2 people, 20.00%
- Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 2 people, 20.00%
- Tension Headache: 1 person, 10.00%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 10.00%
- Diabetes: 1 person, 10.00%
- Heart Valve Incompetence (heart's valves do not work correctly): 1 person, 10.00%
- High Blood Pressure: 1 person, 10.00%
- Hypersensitivity: 1 person, 10.00%
- Indigestion: 1 person, 10.00%
* Approximation only. Some reports may have incomplete information.
Do you take Pantoprazole and have Lung adenocarcinoma metastatic?Check whether Lung adenocarcinoma metastatic is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Lung adenocarcinoma metastatic and when was it recovered:
Expand to all the drugs that have ingredients of pantoprazole sodium:
Alternative drugs to, pros and cons of Pantoprazole:
- Pantoprazole (260,152 reports)
Common Pantoprazole side effects:
- Drug ineffective: 19,200 reports
- Fatigue (feeling of tiredness): 18,779 reports
- Breathing difficulty: 15,737 reports
- Chronic kidney disease: 15,555 reports
- Diarrhea: 15,376 reports
- Pain: 13,857 reports
- Rashes (redness): 12,108 reports
Browse all side effects of Pantoprazole:a b c d e f g h i j k l m n o p q r s t u v w x y z
Lung adenocarcinoma metastatic treatments and more:
- Lung adenocarcinoma metastatic (1,207 reports)
COVID vaccines that are related to Lung adenocarcinoma metastatic:
- Lung adenocarcinoma metastatic in Moderna COVID Vaccine
- Lung adenocarcinoma metastatic in Pfizer BioNTech Covid Vaccine
- Lung adenocarcinoma metastatic in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Lung adenocarcinoma metastatic:
- Lung adenocarcinoma metastatic (360 drugs)
All the conditions that are associated with Lung adenocarcinoma metastatic:
- Lung adenocarcinoma metastatic (168 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on pantoprazole sodium (the active ingredients of Pantoprazole) and Pantoprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cipro and Conjunctival Haemorrhage - 34 seconds ago
- Methotrexate Sodium and Acute Pulmonary Histoplasmosis - 42 seconds ago
- Loraz and Paracetamol Increased - 44 seconds ago
- Gastric Cancer and Ocular Hyperaemia - 45 seconds ago
- Sulfasalazine and Diabeta drug interaction - 46 seconds ago
- Ramipril and Ultiva drug interaction - a minute ago
- Lorazepam and Incision Site Haematoma - a minute ago
- Fentanyl Citrate and Uterine Atony - a minute ago
- Xolair and Kidney Stones - a minute ago
- Dynacirc and Stress Urinary Incontinence - a minute ago